STUDY OF SERUM TOTAL THIOL LEVELS AND LIPID PEROXIDATION AS INDICATOR OF OXIDATIVE STRESS IN PATIENTS OF ACUTE CENTRAL SEROUS RETINOPATHY.

Lam D, Das S, Liu S, et al. Central serous chorioretinopathy. Ryan’s Retina. Section 3. Chapter - 75. 6th edn. Elsevier 2018.

Das S, Das D. Central Serous Chorioretinopathy (CSCR). Major review. Sci J Med & Vis Res Foun 2017;35(3):10-20.               

Kitzmann AS, Pulido JS, Diehl NN, et al. Incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology 2008;115(1):169-73. 

Tsai DC, Chen SJ, Huang CC, et al. Epidemiology of idiopathic CSCR in Taiwan 2001-2006: a population-based study. PLoS One 2013;8(6):e66858.     

Thirunavukkarasu A, Madhiyalagan S. Retrospective study of central serous chorioretinopathy in females at a tertiary care hospital. Indian J of Clinical and Experimental Ophthalmol 2017;3(1):57-60. 

Yannuzzi LA. Type a behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc 1986;84:799-845.             

Wang L, Muxin G, Nishada H, et al. Pshychological stress induced oxidative stress as a model of sub healthy condition and the effect of Traditional Chinese Medicine. Evid Based Complement Alternat Med 2007;4(2):195-202.            

Salim S. Oxidative stress and psychological disorders. Curr Neuropharmacol 2014;12(2):140-7.               

Prakash M, Shetty MS, Tilak P, et al. Total thiols: biomedical importance and their alteration in various disorders. Online Journal of Health and Allied Sci 2009;8(2):2.        

Nielsen F, Mikkelsen BB, Nielsen JB, et al. Plasma malondialdehyde as a biomarker for oxdative stress: reference interval and effects of life-style factors. Clin Chem 1997;43(7):1209-14.               

Gawel S, Wardas M, Niedworok E, et al. Malondialdehyde (MDA) as a lipid peroxidation marker. Wiad Lek 2004:57(9-10):453-5.           

Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutrition, Metabolism and Cardiovascular Diseases 2005;15(4):316-28.             

Balcerczyk A, Grzelak A, Janaszweska A, et al. Thiols as major determinants of total antioxidant capacity. Biofactors 2003;17(1-4):75-82.   

Altinkaynak H, Kurkcuoglu PZ, Caglayan M, et al. A novel marker in acute central serous chorioretinopathy: thiol/ disulphide homeostasis. Int Ophthalmol 2018;38(1):175-81.        

Turkoglu EB, Dikci S, Celik E, et al. Thiol/Disulphide homeostasis in patients with central serous chorioretinopathy. Curr Eye Res 2016;41(11):1489-91.      

Da Costa CM, Dos Santos RCC, Lima ES. A simple automated procedure for thiol measurement in human serum samples. J Bras Patol Med Lab 2006;42(5):345-50.          

Cai J, Nelson KC, Wu M, et al. Oxidative damage and Retinal Pigment Epithelium. Prog Retin Eye Res 2000;19(2):205-21.         

Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine angiography. Retina 1994;14(3):231-42.           

Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996;121(1):26-34. 

Jiang S, Moriartry-Craige SE, Orr M, et al. Oxidant induced apoptosis in human retinal pigment epithelial cells dependence on extracellular redox state. Invest Ophthalmol Vis Sci 2005;46(3):1054-61.           

Dean O, Giorlando F, Berk M. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanism of action. J Psychiatry Neurosci 2011;36(2):78-86.             

Hu ML. Measurement of protein thiol groups and glutathione in plasma. Meth Enzymol 1994;233:380-5.                 

Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95(2):351-8.          

Ratanasukon M, Bhurayanontachai R, Jirarattanasopa P. High dose antioxidants for central serous chorioretinopathy: the random placebo-controlled study. BMC Ophthalmol 2012;12:20.                                

Turkcu FM, Yuksel H, Yuksel H, et al. Serum dehydroepiandrosterone sulphate, total antioxidant capacity and total oxidant status in central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2014;252(1):17-21.              

Kundi H, Ates I, Kiziltunc E, et al. A novel oxidative stress marker in acute myocardial infarction: thiol/disulphide homeostasis. Am J Emerg Med 2015;33(11):1567-71.               

Ates I, Kaplan M, Inan B, et al. How does thiol/disulphide homeostasis change in prediabetic patients? Diabetes Res Clin Pract 2015;110(2):166-71.       

Ates I, Kaplan M, Yuksel M, et al. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine 2016;51(1):47-51.        

Babaoglu E, Kilic H, Hezer H, et al. Comparison of thiol/disulphide homeostasis parameters in patients of COPD, asthma and ACOs. Eur Rev Med Pharmacol Sci 2016;20(8):1537-43.                   

Gumusyayla S, Vural G, Bektas H, et al. A novel oxidative stress marker in patients with Alzheimer’s disease: dynamic thiol/disulphide homeostasis. Acta Neuropsychiatr 2016;28(6):315-20.                             

Ozler S, Erel O, Oztas E, et al. Serum thiol/disulphide homeostasis in preeclampsia. Hypertens Pregnancy 2015;34(4):474-85.        

Qian J, Fang J, Zhu Q, et al. Serum protein thiol levels in patients with hospital-acquired acute kidney injury. Kidney Blood Press Res 2015;40(6):623-9.        

Prakash M, Shetty JK, Tripathy S, et al. Serum total thiol status in alcohol abusers. Asian Journal of Biochemistry 2008;3(1):48-51.               

Gulpamuk B, Koc M, Karatepe MS, et al. Novel assessment of oxidative stress biomarkers in patients with keratoconus: thiol/disulphide homeostasis. Current Eye Research 2017;42(9):1215-9.             

Tetikoglu M, Aktas S, Sagdik HM, et al. Thiol/disulphide homeostasis in pseudoexfoliation syndrome. Current Eye Research 2017;42(6):876-9.      

Elbay A, Ozer OF, Altinisik M, et al. A novel tool reflecting the role of oxidative stress in cataract: thiol/disulphide homeostasis. Scandinavian J Clin Lab Invest 2017;77(3):223-7.                         

Prakash M, Upadhya S, Prabhu R. Protein thiol oxidation and lipid peroxidation in patients of uraemia. Scandinavian J Clin Lab Invest 2004;64(6):599-604.         

Kaur S, Singh SP, Gujral U. Role of Malodialdehyde (MDA) in senile cataract. Journal of Medical Research 2016;2(2):44-6. 

Totan Y, Cekic O, Borazan M, et al. Plasma malondialdehyde and nitric oxide levels in age related macular degeneration. Br J Ophthalmol 2001;85(12):1426-8.      

Choi W, Lian C, Ying L, et al. Expression of lipid peroxidation markers in the tear film and ocular surface of patients with non-Sjogrens syndrome: potential biomarkers for dry eye disease. Curr Eye Res 2016;41(9):1143-9.            

Cejkova J, Cejka C. The role of oxidative stress in corneal diseases and injuries. Histol Histopathol 2015;30(8):893-900.